The impact of Thr91 mutation on c-Src resistance to UM-164: molecular dynamics study revealed a new opportunity for drug design

Abstract

The emergence of a drug resistant non-receptor tyrosine kinase (c-Src) in triple-negative breast cancer (TNBC) remains a prime concern in relation to the burden of TNBC among people living with breast cancer and drug development. Thr91 mutation was found to induce a complete loss of protein conformation required for drug fitness. Herein, we provide the first account of the molecular impact of the Thr91 mutation on c-Src resistance to experimental drug UM-164 using various computational approaches, namely molecular dynamics simulation, principal component analysis (PCA), dynamic cross-correlation matrices (DCCM) analysis, hydrogen bond occupancy, thermodynamics calculation, ligand-residue interaction and residue interaction networks (RINs). Findings from this study revealed that Thr91 mutation leads to a steric conflict between UM-164 and the side chain of methionine (Met91); this mutation distorts the UM-164 optimum orientation on the conformational space of mutant c-Src compared to the wild-type; decreases hydrogen bond formation between the residues in the mutant protein structure; decreases the UM-164 binding energy in the mutant by -13.416 kcal mol; reduces the residue correlation in the mutant protein structure; induces a change in the overall protein structure conformation from an inactive to active conformation; and distorts the ligand atomic interaction network and the residue interaction network. This report provides important insights that will assist in the further design of novel dual kinase inhibitors to minimise the chances of drug resistance in triple negative breast cancer.

Dynamic perspectives into the mechanisms of mutation‐induced p53‐DNA binding loss and inactivation using active perturbation theory: Structural and molecular insights toward the design of potent reactivators in cancer therapy

“…Moreover, centrality measures were also computed using the RINspector plugin . These include node degree, diameter, density, short path length, betweenness, and closeness centrality …”

Covalent vs. Non‐Covalent Inhibition: Tackling Drug Resistance in EGFR – A Thorough Dynamic Perspective

“…[58] Principle Component Analysis (PCA) PCA is a covariance-matrix-based statistical technique to identify the most significant motions in backbone Cα atoms of the receptor during a simulation through visual inspection. [59,60] PCA reduces dimensionality data obtained from MD simulations to extract the most important modes responsible for conformation. Usually, the first two principal components (PC1 and PC2) with higher Eigenvalues of the covariance matrix describe the first and second slowest motion modes of the systems, respectively, and indicate the most important conformation changes of biological sys-tems.…”

Targeting HCV polymerase: a structural and dynamic perspective into the mechanism of selective covalent inhibition

“…49,50 Although the MM/GBSA technique lacks the required accuracy for absolute BFE estimates, 51,54 several previous reports including studies from this research group have successfully used the MM/GBSA approach in obtaining relative BFE for MD simulated systems which have been validated with experimental ndings. 38,49,[55][56][57][58][59] To obtain individual residue contributions to the total BFE prole of compound 47 with the HCV RdRp, per residue free energy decomposition was performed at an atomic level for all the important residues using the MM/ GBSA method of Amber14.…”